- Home
- HUYA vs COLL Comparison
HUYA vs COLL Comparison
Compare HUYA & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUYA
- COLL
- Stock Information
- Founded
- HUYA 2014
- COLL 2002
- Country
- HUYA China
- COLL United States
- Employees
- HUYA N/A
- COLL N/A
- Industry
- HUYA Computer Software: Programming Data Processing
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- HUYA Technology
- COLL Health Care
- Exchange
- HUYA Nasdaq
- COLL Nasdaq
- Market Cap
- HUYA 827.0M
- COLL 958.8M
- IPO Year
- HUYA 2018
- COLL 2015
- Fundamental
- Price
- HUYA $3.55
- COLL $35.54
- Analyst Decision
- HUYA Buy
- COLL Strong Buy
- Analyst Count
- HUYA 3
- COLL 4
- Target Price
- HUYA $4.57
- COLL $44.25
- AVG Volume (30 Days)
- HUYA 1.6M
- COLL 463.5K
- Earning Date
- HUYA 11-11-2025
- COLL 11-06-2025
- Dividend Yield
- HUYA 70.64%
- COLL N/A
- EPS Growth
- HUYA N/A
- COLL N/A
- EPS
- HUYA N/A
- COLL 1.06
- Revenue
- HUYA $852,782,043.00
- COLL $707,007,000.00
- Revenue This Year
- HUYA $8.09
- COLL $22.23
- Revenue Next Year
- HUYA $4.90
- COLL $2.78
- P/E Ratio
- HUYA N/A
- COLL $34.38
- Revenue Growth
- HUYA N/A
- COLL 22.61
- 52 Week Low
- HUYA $2.21
- COLL $23.23
- 52 Week High
- HUYA $6.43
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- HUYA 54.01
- COLL 43.47
- Support Level
- HUYA $3.31
- COLL $34.71
- Resistance Level
- HUYA $3.55
- COLL $39.12
- Average True Range (ATR)
- HUYA 0.20
- COLL 1.24
- MACD
- HUYA -0.00
- COLL -0.64
- Stochastic Oscillator
- HUYA 46.23
- COLL 16.37
About HUYA HUYA Inc. American depositary shares each representing one ordinary share
Established in 2011, Huya is the largest online game livestreaming company in China. Headquartered in Guangzhou, Huya mainly provides livestreamed videos on esports games such as League of Legends and Honor of Kings and collects virtual tips from viewers. Its products include the Huya Live platform in China and Nimo TV in Southeast Asia and South America. As of 2024, Huya was a subsidiary of Tencent, which owned 63% of its equity stake and held 94% of the voting power.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.